{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:01:20Z","timestamp":1790283680365,"version":"4.1.0"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,10,20]]},"published-print":{"date-parts":[[2026,2]]},"DOI":"10.2967\/jnumed.125.270850","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T20:25:15Z","timestamp":1763670315000},"page":"210-216","source":"Crossref","is-referenced-by-count":3,"title":["[\n                    <sup>68<\/sup>\n                    Ga]Ga-FAPI-46 PET\/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[\n                    <sup>18<\/sup>\n                    F]FDG PET\/CT and Contrast-Enhanced CT: Results from a Prospective Observational Study"],"prefix":"10.2967","volume":"67","author":[{"given":"Timo","family":"Bartel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Barg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph A.","family":"Berliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Hamacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Falkenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens T.","family":"Siveke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"2026020205350894000_67.2.210.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.005"},{"key":"2026020205350894000_67.2.210.2","doi-asserted-by":"crossref","first-page":"672500","DOI":"10.3389\/fonc.2021.672500","article-title":"Early and next-generation KIT\/PDGFRA kinase inhibitors and the future of treatment for advanced gastrointestinal stromal tumor","volume":"11","author":"Bauer","year":"2021","journal-title":"Front Oncol."},{"key":"2026020205350894000_67.2.210.3","first-page":"17","article-title":"The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors","volume":"45","author":"Gayed","year":"2004","journal-title":"J Nucl Med."},{"key":"2026020205350894000_67.2.210.4","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.2147\/CMAR.S275422","article-title":"Normogram to predict preoperative occult peritoneal metastasis of gastrointestinal stromal tumors (GIST) based on imaging and inflammatory indexes","volume":"12","author":"Xu","year":"2020","journal-title":"Cancer Manag Res."},{"key":"2026020205350894000_67.2.210.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2010.09.017"},{"key":"2026020205350894000_67.2.210.6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s40001-022-00806-9","article-title":"Clinical significance of 18F-FDG PET\/CT imaging in 32 cases of gastrointestinal stromal tumors","volume":"27","author":"Du","year":"2022","journal-title":"Eur J Med Res."},{"key":"2026020205350894000_67.2.210.7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11307-022-01729-x","article-title":"Comparison of 68Ga-FAPI PET\/CT and 18FDG PET\/CT modalities in gastrointestinal system malignancies with peritoneal involvement","volume":"24","author":"Elboga","year":"2022","journal-title":"Mol Imaging Biol."},{"key":"2026020205350894000_67.2.210.8","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","article-title":"Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT","volume":"48","author":"Zhao","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026020205350894000_67.2.210.9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12149-025-02022-x","article-title":"FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?","volume":"39","author":"Garca Megas","year":"2025","journal-title":"Ann Nucl Med."},{"key":"2026020205350894000_67.2.210.10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00259-022-05955-x","article-title":"[18F]FAPI-42 PET\/CT versus [18F]FDG PET\/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors","volume":"50","author":"Wu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026020205350894000_67.2.210.11","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.21037\/qims-24-192","article-title":"Predictive performance of [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography\/computed tomography (PET\/CT) in evaluating response of recurrent or metastatic gastrointestinal stromal tumors: complementary or alternative to [18F]fluorodeoxyglucose (FDG) PET\/CT?","volume":"14","author":"Wu","year":"2024","journal-title":"Quant Imaging Med Surg."},{"key":"2026020205350894000_67.2.210.12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nucmedbio.2022.04.010","article-title":"[68Ga]\/[90Y]FAPI-46: automated production and analytical validation of a theranostic pair","volume":"110111","author":"Nader","year":"2022","journal-title":"Nucl Med Biol."},{"key":"2026020205350894000_67.2.210.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.269002"},{"key":"2026020205350894000_67.2.210.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x"},{"key":"2026020205350894000_67.2.210.15","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2026020205350894000_67.2.210.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227967"},{"key":"2026020205350894000_67.2.210.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264827"},{"key":"2026020205350894000_67.2.210.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266411"},{"key":"2026020205350894000_67.2.210.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267248"},{"key":"2026020205350894000_67.2.210.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262096"},{"key":"2026020205350894000_67.2.210.21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00259-024-06795-7","article-title":"Feasibility and therapeutic potential of [177Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcoma","volume":"52","author":"Banihashemian","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026020205350894000_67.2.210.22","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/1078-0432.CCR-22-1432","article-title":"Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities","volume":"28","author":"Fendler","year":"2022","journal-title":"Clin Cancer Res."},{"key":"2026020205350894000_67.2.210.23","first-page":"251524","article-title":"68Ga-FAPI-46 PET for imaging of FAP-expressing cancer: results from a prospective, single-arm, interventional phase 2 clinical trial","volume":"66","author":"Pabst","year":"2025","journal-title":"J Nucl Med."},{"key":"2026020205350894000_67.2.210.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265215"},{"key":"2026020205350894000_67.2.210.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265245"},{"key":"2026020205350894000_67.2.210.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269914"},{"key":"2026020205350894000_67.2.210.27","first-page":"S1","article-title":"68Ga-FAPI-46 in patients with gastrointestinal stromal tumors (GIST): an update of a single-center, prospective, observational study (NCT04571086)","volume":"51","author":"Bartel","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.270850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:24Z","timestamp":1785269904000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.270850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.2967\/jnumed.125.270850"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.270850","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}